BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Favresse J, Burlacu M, Maiter D, Gruson D. Interferences With Thyroid Function Immunoassays: Clinical Implications and Detection Algorithm. Endocrine Reviews 2018;39:830-50. [DOI: 10.1210/er.2018-00119] [Cited by in Crossref: 103] [Cited by in F6Publishing: 106] [Article Influence: 20.6] [Reference Citation Analysis]
Number Citing Articles
1 D'Aurizio F, Kratzsch J, Gruson D, Petranović Ovčariček P, Giovanella L. Free thyroxine measurement in clinical practice: how to optimize indications, analytical procedures, and interpretation criteria while waiting for global standardization. Crit Rev Clin Lab Sci 2023;60:101-40. [PMID: 36227760 DOI: 10.1080/10408363.2022.2121960] [Reference Citation Analysis]
2 Praw SS, Brent GA. Approach to the Patient With a Suppressed TSH. J Clin Endocrinol Metab 2023;108:472-82. [PMID: 36329632 DOI: 10.1210/clinem/dgac635] [Reference Citation Analysis]
3 Echterdiek F, Ranke MB, Schwenger V, Heemann U, Latus J. Kidney disease and thyroid dysfunction: the chicken or egg problem. Pediatr Nephrol 2022;37:3031-42. [PMID: 35737115 DOI: 10.1007/s00467-022-05640-z] [Reference Citation Analysis]
4 Vidouris M, Worth C, Patel L, Date A, Jasser A, Hird B, Tetlow L, Banerjee I. Notes for the general paediatrician: managing thyrotoxicosis in children and young people. BMJ Paediatr Open 2022;6. [PMID: 36645751 DOI: 10.1136/bmjpo-2022-001582] [Reference Citation Analysis]
5 Barbesino G, Algeciras-schimnich A, Bornhorst J. Thyroglobulin Assay Interferences: Clinical Usefulness of Mass-Spectrometry Methods. Journal of the Endocrine Society 2022;7. [DOI: 10.1210/jendso/bvac169] [Reference Citation Analysis]
6 Braunstein GD. Spurious Serum Hormone Immunoassay Results: Causes, Recognition, Management. touchREV Endocrinol 2022;18:141-7. [PMID: 36694886 DOI: 10.17925/EE.2022.18.2.141] [Reference Citation Analysis]
7 Alegre E, Casal H, Galofré JC, González Á. Questionable High Free T4 Concentrations: When Confirming against an Alternative Method Is Not Enough. Clin Chem 2022;68:1128-32. [PMID: 36048192 DOI: 10.1093/clinchem/hvac114] [Reference Citation Analysis]
8 Giovanella L, Duntas L, D'Aurizio F, Kurka H, Ammer T, Rank CM, Visser WE, van den Berg SAA. How to approach clinically discordant FT4 results when changing testing platforms: real-world evidence. Endocrine 2022;77:333-9. [PMID: 35689789 DOI: 10.1007/s12020-022-03098-5] [Reference Citation Analysis]
9 Favresse J, Schiettecatte J, Wolff F, Cotton F, Elsen M, Eucher C, Rosseels C, Anckaert E. Two-site evaluation of the Roche Elecsys Vitamin D total III assay. Clinical Chemistry and Laboratory Medicine (CCLM) 2022;0. [DOI: 10.1515/cclm-2022-0177] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Choi R, Lee SG, Lee EH. Patient Population and Test Utilization for Thyroid Function in Local Clinics and Hospitals in Korea. Diagnostics 2022;12:1638. [DOI: 10.3390/diagnostics12071638] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Fitzgerald SP, Falhammar H. Redefinition of Successful Treatment of Patients With Hypothyroidism. Is TSH the Best Biomarker of Euthyroidism? Front Endocrinol 2022;13:920854. [DOI: 10.3389/fendo.2022.920854] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Donnars A, Leplat A, Grosheny C, Briet C, Illouz F, Bouzamondo N, Moal V, Boux De Casson F, Bouhours-Nouet N, Coutant R, Rodien P, Mirebeau-Prunier D, Dieu X. Clinically symptomatic resistance to thyroid hormone β syndrome due to THRB gene mosaicism. J Clin Endocrinol Metab 2022:dgac347. [PMID: 35689814 DOI: 10.1210/clinem/dgac347] [Reference Citation Analysis]
13 Flores-rebollar A. Reply: Subacute thyroiditis after anti-SARS-CoV-2 (Ad5-nCoV) vaccine. Enfermedades infecciosas y microbiologia clinica (English ed ) 2022;40:345-346. [DOI: 10.1016/j.eimce.2022.03.005] [Reference Citation Analysis]
14 Chaker L, Razvi S, Bensenor IM, Azizi F, Pearce EN, Peeters RP. Hypothyroidism. Nat Rev Dis Primers 2022;8:30. [PMID: 35589725 DOI: 10.1038/s41572-022-00357-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
15 Gild ML, Stuart M, Clifton-Bligh RJ, Kinahan A, Handelsman DJ. Thyroid Hormone Abuse in Elite Sports: The Regulatory Challenge. J Clin Endocrinol Metab 2022:dgac223. [PMID: 35438767 DOI: 10.1210/clinem/dgac223] [Reference Citation Analysis]
16 Carducci S, Mian C. Frequenti interferenze di laboratorio negli esami di funzione tiroidea: presentazione di due casi. L'Endocrinologo 2022;23:196-198. [DOI: 10.1007/s40619-022-01058-9] [Reference Citation Analysis]
17 Wauthier L, Plebani M, Favresse J. Interferences in immunoassays: review and practical algorithm. Clin Chem Lab Med 2022. [PMID: 35304841 DOI: 10.1515/cclm-2021-1288] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
18 Külz M, Fellner S, Rocktäschel J, Ceglarek U, Willenberg A, Kratzsch J. Dubiously increased FT4 and FT3 levels in clinically euthyroid patients: clinical finding or analytical pitfall? Clin Chem Lab Med 2022. [PMID: 35213944 DOI: 10.1515/cclm-2021-1211] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Morcel P, Hadjadj S, Ansquer C, Yan Lun A, Cariou B, Delemazure Chesneau A, Le Bras M, Langlois E, Drui D. Démarche diagnostique et prise en charge thérapeutique de l’hyperthyroïdie. La Revue de Médecine Interne 2022. [DOI: 10.1016/j.revmed.2021.12.009] [Reference Citation Analysis]
20 Ariyawansa C, Lim EM, Kodali V. The Importance of Discordance. Clinical Chemistry 2022;68:370-1. [DOI: 10.1093/clinchem/hvab196] [Reference Citation Analysis]
21 Ghazal K, Brabant S, Prie D, Piketty ML. Hormone Immunoassay Interference: A 2021 Update. Ann Lab Med 2022;42:3-23. [PMID: 34374345 DOI: 10.3343/alm.2022.42.1.3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
22 Peverelli E, Giardino E, Treppiedi D, Catalano R, Mangili F, Mantovani G. TSH-oma. Pituitary Adenomas 2022. [DOI: 10.1007/978-3-030-90475-3_8] [Reference Citation Analysis]
23 Soni M, Danalakshmi S. Spuriously low thyroid-stimulating hormone? A laboratory phenomenon. Apollo Med 2022;0:0. [DOI: 10.4103/am.am_81_22] [Reference Citation Analysis]
24 Rezaei B, Mandani S. Sensor Systems for Drug Analysis Their Interferences. Biosensing and Micro-Nano Devices 2022. [DOI: 10.1007/978-981-16-8333-6_11] [Reference Citation Analysis]
25 Espiard S. Troubles de la sensibilité aux hormones thyroïdiennes. Les Maladies de la Thyroïde 2022. [DOI: 10.1016/b978-2-294-77583-3.00017-4] [Reference Citation Analysis]
26 Greenman Y. Thyrotrophin-Secreting Pituitary Adenomas. The Pituitary 2022. [DOI: 10.1016/b978-0-323-99899-4.00012-3] [Reference Citation Analysis]
27 Raverot V, d'Herbomez M. Évaluation biologique de la fonction thyroïdienne. Les Maladies de la Thyroïde 2022. [DOI: 10.1016/b978-2-294-77583-3.00003-4] [Reference Citation Analysis]
28 Waidyanatha S, Fletcher BL, Fernando RA, Cora MC, Silinski MAR. Development and validation of an ultraperformance liquid chromatography-tandem mass spectrometry method for quantitation of total 3,3',5-triiodo-L-thyronine and 3,3',5,5'-tetraiodo-L-thyronine in rodent serum. Anal Lett 2022;55:796-811. [PMID: 35812014 DOI: 10.1080/00032719.2021.1967969] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Nicolai E, Nuccetelli M, Sarubbi S, Basile V, Perrone MA, Terrinoni A, Minieri M, Pieri M, Bernardini S. Performance evaluation of the new Chemiluminescence Immunoassay CL-1200i Thyroid Panel. J Immunoassay Immunochem 2021;:1-13. [PMID: 34927566 DOI: 10.1080/15321819.2021.2017301] [Reference Citation Analysis]
30 Effraimidis G, Maria Hilsted L, Feldt-rasmussen U. Biotin Use Can Interfere with the Management of Thyroid Diseases, Including Thyroid Cancer. Clinical Thyroidology 2021;33:520-2. [DOI: 10.1089/ct.2021;33.520-522] [Reference Citation Analysis]
31 Goettemoeller T, McShane AJ, Rao P. Misleading FT4 and FT3 Due to Immunoassay Interference From Autoantibodies. Clin Biochem 2021:S0009-9120(21)00314-3. [PMID: 34848174 DOI: 10.1016/j.clinbiochem.2021.11.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Develtere T, Duyck F, Vanhauwaert D, Dedeurwaerdere F, Spincemaille K. Thyreotroop adenoom van de hypofyse: een zeldzame oorzaak van hyperthyreoïdie. Tijdschr Geneesk 2021. [DOI: 10.47671/tvg.77.21.131] [Reference Citation Analysis]
33 Mandal K, Ashorobi D, Lee A, Liao H, Kumar SC, Rosenthal DS. Factitiously Elevated Total Triiodothyronine in a Euthyroid Patient with Multiple Myeloma. Case Rep Endocrinol 2021;2021:8479193. [PMID: 34497729 DOI: 10.1155/2021/8479193] [Reference Citation Analysis]
34 Padoan A, Clerico A, Zaninotto M, Trenti T, Tozzoli R, Aloe R, Alfano A, Rizzardi S, Dittadi R, Migliardi M, Bagnasco M, Plebani M. Percentile transformation and recalibration functions allow harmonization of thyroid-stimulating hormone (TSH) immunoassay results. Clin Chem Lab Med 2020;58:1663-72. [PMID: 31927515 DOI: 10.1515/cclm-2019-1167] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
35 D'Arcy R, Hunter S, Spence K, McDonnell M. A Case of macro-TSH masquerading as subclinical hypothyroidism. BMJ Case Rep 2021;14:e243436. [PMID: 34253523 DOI: 10.1136/bcr-2021-243436] [Reference Citation Analysis]
36 Favresse J, Bayart JL, Burlacu MC, Maiter D, Dogné JM, Douxfils J, Gruson D. Usefulness of a Non-Streptavidin Bead Technology to Overcome Biotin Interference: Proof of Principle with 25-OH Vitamin D, TSH, and FT4. J Appl Lab Med 2021;6:1072-7. [PMID: 33382887 DOI: 10.1093/jalm/jfaa203] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Köhrle J, Frädrich C. Thyroid hormone system disrupting chemicals. Best Pract Res Clin Endocrinol Metab 2021;:101562. [PMID: 34274233 DOI: 10.1016/j.beem.2021.101562] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
38 Metwalley KA, Farghaly HS. Subclinical hypothyroidism in children: updates for pediatricians. Ann Pediatr Endocrinol Metab 2021;26:80-5. [PMID: 34218629 DOI: 10.6065/apem.2040242.121] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Ohba K. An Update on the Pathophysiology and Diagnosis of Inappropriate Secretion of Thyroid-Stimulating Hormone. Int J Mol Sci 2021;22:6611. [PMID: 34205543 DOI: 10.3390/ijms22126611] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
40 Frutiger A, Tanno A, Hwu S, Tiefenauer RF, Vörös J, Nakatsuka N. Nonspecific Binding-Fundamental Concepts and Consequences for Biosensing Applications. Chem Rev 2021;121:8095-160. [PMID: 34105942 DOI: 10.1021/acs.chemrev.1c00044] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 13.5] [Reference Citation Analysis]
41 Ylli D, Soldin SJ, Stolze B, Wei B, Nigussie G, Nguyen H, Mendu DR, Mete M, Wu D, Gomes-Lima CJ, Klubo-Gwiezdzinska J, Burman KD, Wartofsky L. Biotin Interference in Assays for Thyroid Hormones, Thyrotropin and Thyroglobulin. Thyroid 2021;31:1160-70. [PMID: 34042535 DOI: 10.1089/thy.2020.0866] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
42 Leese G, Soto-Pedre E. Time to refresh thinking on the terminology and management of hypothyroidism? Clin Endocrinol (Oxf) 2021. [PMID: 33990990 DOI: 10.1111/cen.14485] [Reference Citation Analysis]
43 Yin Y, Zhao F, Hu Y, Lu L, Qiu L. Consideration triggered by the choice of heterophilic antibody interference detection tests in measuring ACTH for a teenager boy with a rare adrenal disease. Clin Chim Acta 2021;519:210-3. [PMID: 33991519 DOI: 10.1016/j.cca.2021.05.007] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Siskind SM, Lee SY, Pearce EN. Investigating hypothyroidism. BMJ. [DOI: 10.1136/bmj.n993] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
45 Soleimani R, Favresse J, Roy T, Gruson D, Fillée C. Macro vitamin B12: an underestimated threat. Clin Chem Lab Med 2020;58:408-15. [PMID: 31665115 DOI: 10.1515/cclm-2019-0999] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
46 Wouters Y, Oosterbos J, Reynaert N, Penders J. Alarmed by misleading interference in free T3 and free T4 assays: a new case of anti-streptavidin antibodies. Clin Chem Lab Med 2020;58:e69-71. [PMID: 31605576 DOI: 10.1515/cclm-2019-0845] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
47 Zaninotto M, Plebani M. Understanding and managing interferences in clinical laboratory assays: the role of laboratory professionals. Clin Chem Lab Med 2020;58:350-6. [PMID: 31622245 DOI: 10.1515/cclm-2019-0898] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
48 Ruth I, Mathieu E, Burniat A, Fage D, Cotton F, Wolff F. Interferences in free thyroxine concentration using the Roche analytical platform: improvement of the third generation? Clin Chem Lab Med 2020;58:e36-9. [PMID: 31377735 DOI: 10.1515/cclm-2019-0525] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
49 Ting MJM, Zhang R, Lim EM, Ward BK, Wilson SG, Walsh JP. Familial Dysalbuminemic Hyperthyroxinemia as a Cause for Discordant Thyroid Function Tests. J Endocr Soc 2021;5:bvab012. [PMID: 33728390 DOI: 10.1210/jendso/bvab012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Pan Q, Zhang Y, Zhang W, Hu Y, Chen Z, Liu A, Wang G. The Prevalence of Euthyroid Hypertriiodothyroninemia in Newly Diagnosed Multiple Myeloma and its Clinical Characteristics. Endocr Pract 2021;27:236-40. [PMID: 33779557 DOI: 10.1016/j.eprac.2020.09.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Harley K, Bissonnette S, Inzitari R, Schulz K, Apple FS, Kavsak PA, Gunsolus IL. Independent and combined effects of biotin and hemolysis on high-sensitivity cardiac troponin assays. Clin Chem Lab Med 2021;59:1431-43. [PMID: 33761581 DOI: 10.1515/cclm-2021-0124] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
52 Kim EI, Dimitrova DА, Dimitrova DA, Katamadze NN, Dzantieva TS. Endogenous and exogenous interferences in thyroid function immunoassays. Clin Exp Thyroid 2021;16:16-24. [DOI: 10.14341/ket12698] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 Mairesse A, Wauthier L, Courcelles L, Luyten U, Burlacu MC, Maisin D, Favresse J, van Dievoet MA, Gruson D. Biological variation and analytical goals of four thyroid function biomarkers in healthy European volunteers. Clin Endocrinol (Oxf) 2021;94:845-50. [PMID: 33107075 DOI: 10.1111/cen.14356] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
54 Fonseca L, Benido VS, Pessanha J, Pereira MT, Vilaverde J, Dores J. Being alert on thyroid function tests interpretation: A case report of heterophile antibody interference in serum in a pregnant woman. Ann Endocrinol (Paris) 2021;82:121-3. [PMID: 33727115 DOI: 10.1016/j.ando.2021.03.001] [Reference Citation Analysis]
55 Effraimidis G, Watt T, Feldt-Rasmussen U. Levothyroxine Therapy in Elderly Patients With Hypothyroidism. Front Endocrinol (Lausanne) 2021;12:641560. [PMID: 33790867 DOI: 10.3389/fendo.2021.641560] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
56 Jiménez García C, Ortega Fernández P, Torregrosa Quesada ME, González Bueno V, Botella Belda MT, Alfayate Guerra R. Falso hipertiroidismo por interferencia en inmunoanálisis. Advances in Laboratory Medicine / Avances en Medicina de Laboratorio 2021;2:125-128. [DOI: 10.1515/almed-2020-0047] [Reference Citation Analysis]
57 Jiménez García C, Ortega Fernández P, Torregrosa Quesada ME, González Bueno V, Botella Belda MT, Guerra RA. False hyperthyroidism caused by interference in immunoassays. Advances in Laboratory Medicine / Avances en Medicina de Laboratorio 2021;2:121-124. [DOI: 10.1515/almed-2020-0097] [Reference Citation Analysis]
58 Țaranu I, Lazea C, Creț V, Răcătăianu N, Iancu M, Bolboacă SD. Inflammation-Related Markers and Thyroid Function Measures in Pediatric Patients: Is the Grade of Obesity Relevant? Diagnostics (Basel) 2021;11:485. [PMID: 33803348 DOI: 10.3390/diagnostics11030485] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
59 D'Aurizio F. The role of laboratory medicine in the diagnosis of the hyperthyroidism. Q J Nucl Med Mol Imaging 2021;65:91-101. [PMID: 33565846 DOI: 10.23736/S1824-4785.21.03344-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Feldt-Rasmussen U, Effraimidis G, Klose M. The hypothalamus-pituitary-thyroid (HPT)-axis and its role in physiology and pathophysiology of other hypothalamus-pituitary functions. Mol Cell Endocrinol 2021;525:111173. [PMID: 33549603 DOI: 10.1016/j.mce.2021.111173] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
61 Gant Kanegusuku A, Araque KA, Nguyen H, Wei B, Hosseini S, Soldin SJ. The effect of specific binding proteins on immunoassay measurements of total and free thyroid hormones and cortisol. Ther Adv Endocrinol Metab 2021;12:2042018821989240. [PMID: 33552466 DOI: 10.1177/2042018821989240] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
62 Dahll LK, Haave EM, Dahl SR, Aas FE, Thorsby PM. Endogenous anti-streptavidin antibodies causing erroneous laboratory results more common than anticipated. Scandinavian Journal of Clinical and Laboratory Investigation 2021;81:92-103. [DOI: 10.1080/00365513.2020.1858493] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
63 Mrazek C, Lippi G, Keppel MH, Felder TK, Oberkofler H, Haschke-Becher E, Cadamuro J. Errors within the total laboratory testing process, from test selection to medical decision-making - A review of causes, consequences, surveillance and solutions. Biochem Med (Zagreb) 2020;30:020502. [PMID: 32550813 DOI: 10.11613/BM.2020.020502] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
64 Dasgupta A, Wahed A. Endocrinology. Clinical Chemistry, Immunology and Laboratory Quality Control 2021. [DOI: 10.1016/b978-0-12-815960-6.00003-0] [Reference Citation Analysis]
65 Devaraj S, Garnett E. Thyroid disease and laboratory assessment. Handbook of Diagnostic Endocrinology 2021. [DOI: 10.1016/b978-0-12-818277-2.00003-0] [Reference Citation Analysis]
66 Magne F, Van Vliet G, Delvin EE. Biochemical and molecular evaluation of thyroid gland disorders in children. Biochemical and Molecular Basis of Pediatric Disease 2021. [DOI: 10.1016/b978-0-12-817962-8.00035-4] [Reference Citation Analysis]
67 Cheng X, Guo X, Chai X, Hu Y, Lian X, Zhang G. Heterophilic antibody interference with TSH measurement on different immunoassay platforms. Clin Chim Acta 2021;512:63-5. [PMID: 33285118 DOI: 10.1016/j.cca.2020.11.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
68 Westcott GP, Mulla CM, Hennessey JV. USE OF THE FREE THYROXINE INDEX TO REFINE THE LOWER LIMIT OF A FREE THYROXINE IMMUNOASSAY FOR DETECTION OF SECONDARY HYPOTHYROIDISM. Endocr Pract 2021;27:8-14. [PMID: 33475506 DOI: 10.4158/EP-2020-0210] [Reference Citation Analysis]
69 Razvi S, Mrabeti S, Luster M. Managing symptoms in hypothyroid patients on adequate levothyroxine: a narrative review. Endocr Connect 2020;9:R241-50. [PMID: 33112818 DOI: 10.1530/EC-20-0205] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
70 Rodríguez JAD, García MIP, Bauça JM, Mullor RV, Barceló A. Persistently increased vitamin B12 concentration due to cobalamin macrocomplexes: a case report and review of the literature. Clin Chem Lab Med 2020;58:e237-9. [PMID: 31926070 DOI: 10.1515/cclm-2019-1010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
71 Larsen CB, Petersen ERB, Overgaard M, Bonnema SJ. Macro-TSH: A Diagnostic Challenge. Eur Thyroid J 2021;10:93-7. [PMID: 33777825 DOI: 10.1159/000509184] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
72 Dieu X, Bouzamondo N, Briet C, Illouz F, Moal V, Boux de Casson F, Bouhours-Nouet N, Reynier P, Coutant R, Rodien P, Mirebeau-Prunier D. Familial Dysalbuminemic Hyperthyroxinemia: An Underdiagnosed Entity. J Clin Med 2020;9:E2105. [PMID: 32635414 DOI: 10.3390/jcm9072105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
73 Korevaar TI. Do Women with Gestational Subclinical Hypothyroidism Require Postpartum Monitoring? Clinical Thyroidology 2020;32:266-9. [DOI: 10.1089/ct.2020;32.266-269] [Reference Citation Analysis]
74 Lewandowski KC, Dąbrowska K, Basińska-Lewandowska M, Bolanowski M, Ruchała M, Lewiński A. Adequate timing and constant supervision are the keys for successful implementation of levothyroxine or levothyroxine/paracetamol absorption test. Thyroid Res 2020;13:5. [PMID: 32467734 DOI: 10.1186/s13044-020-00079-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
75 Goichot B, Raverot V, Klein M, Vija Racaru L, Abeillon-Du Payrat J, Lairez O, Leroy R, Cailleux A, Wolff P, Groussin L, Kaltenbach G, Caron P. Management of thyroid dysfunctions in the elderly. French Endocrine Society consensus statement 2019. Long version. Ann Endocrinol (Paris) 2020;81:89-100. [PMID: 32416938 DOI: 10.1016/j.ando.2020.04.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
76 Khoo S, Lyons G, McGowan A, Gurnell M, Oddy S, Visser WE, van den Berg S, Halsall D, Taylor K, Chatterjee K, Moran C. Familial dysalbuminaemic hyperthyroxinaemia interferes with current free thyroid hormone immunoassay methods. Eur J Endocrinol 2020;182:533-8. [PMID: 32213658 DOI: 10.1530/EJE-19-1021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
77 Concolino P, Costella A, Paragliola RM. Mutational Landscape of Resistance to Thyroid Hormone Beta (RTHβ). Mol Diagn Ther 2019;23:353-68. [PMID: 30976996 DOI: 10.1007/s40291-019-00399-w] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
78 Mzougui S, Favresse J, Soleimani R, Fillée C, Gruson D. Biotin interference: evaluation of a new generation of electrochemiluminescent immunoassays for high-sensitive troponin T and thyroid-stimulating hormone testing. Clinical Chemistry and Laboratory Medicine (CCLM) 2020;58:2037-45. [DOI: 10.1515/cclm-2020-0214] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
79 Paragliola RM, Corsello A, Papi G, Melfa E, Urbani A, Pontecorvi A, Corsello SM, Carrozza C. Immunoassay Interference on Thyroid Function Tests During Treatment with Nivolumab. Thyroid 2020;30:1091-4. [PMID: 32122271 DOI: 10.1089/thy.2019.0799] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
80 Vandendriessche B, Lapauw B, Kaufman JM, Fiers T. A practical approach towards the evaluation of aberrant thyroid function tests. Acta Clin Belg 2020;75:155-62. [PMID: 30806594 DOI: 10.1080/17843286.2019.1577531] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
81 Timmons JG, Mukhopadhyay B. Hyperthyroxinemia with a non-suppressed TSH: how to confidently reach a diagnosis in this clinical conundrum. Hormones (Athens) 2020;19:311-5. [PMID: 32128699 DOI: 10.1007/s42000-020-00180-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
82 Lundin MS, Alratroot A, Abu Rous F, Aldasouqi S. When thyroid labs do not add up, physicians should ask patients about biotin supplements. BMJ Case Rep 2020;13:e231337. [DOI: 10.1136/bcr-2019-231337] [Reference Citation Analysis]
83 Favresse J, Stoefs A, Bayart JL, Burlacu MC, Maisin D, Maiter D, Gruson D. A Challenging Case of Falsely Elevated Free Thyroid Hormones. J Appl Lab Med 2020;5:406-11. [PMID: 32445369 DOI: 10.1093/jalm/jfz027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
84 Sriwijitalai W, Wiwanitkit V. Mildly Elevated TSH, High Free T3, and Normal Free T4: Antiidiotype Antibody Effect. Indian J Endocrinol Metab 2020;24:226-7. [PMID: 32699800 DOI: 10.4103/ijem.IJEM_647_19] [Reference Citation Analysis]
85 Favresse J, Bayart J, Stoefs A, Gheldof D, Douxfils J, Dogné J, Gruson D. Neutralization of biotin interference: preliminary evaluation of the VeraTest Biotin™, VeraPrep Biotin™ and BioT-Filter ®. Clinical Chemistry and Laboratory Medicine (CCLM) 2020;58:e130-3. [DOI: 10.1515/cclm-2019-1121] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
86 Rahimkhani M, Kazemian K, Daryasari RR. Falsely undetectable TSH in a euthyroid patient. Thyroid Res 2020;13:2. [PMID: 32021655 DOI: 10.1186/s13044-020-0076-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
87 Bayart JL, Favresse J, Stoefs A, Closset M, Roy T, Fillée C, Rodriguez-Villalobos H, Kabamba-Mukadi B, Gruson D. Biotin interferences: Have we neglected the impact on serological markers? Clin Chim Acta 2020;503:107-12. [PMID: 31978405 DOI: 10.1016/j.cca.2020.01.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
88 Kuzmanovska S, Vaskova O. Interference in thyroid function immunoassays: clinical consequences. Maced Pharm Bull 2020;66:73-78. [DOI: 10.33320/maced.pharm.bull.2020.66.01.008] [Reference Citation Analysis]
89 John M, Veetil V. Management of thyroid diseases during pandemic: A narrative review. Thyroid Res Pract 2020;17:62. [DOI: 10.4103/trp.trp_35_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
90 Chitra S, Veechika P. Multiple myeloma masquerading as T3 toxicosis. Thyroid Res Pract 2020;17:152. [DOI: 10.4103/trp.trp_46_20] [Reference Citation Analysis]
91 Meng QH. Evolving hyperthyroidism? Clinical Biochemistry 2020;75:83-4. [DOI: 10.1016/j.clinbiochem.2019.11.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
92 Araque KA, Klubo-Gwiezdzinska J, Nieman LK, Welsh K, Soldin SJ. Assessment of thyroid function tests and harmonization: opinion on thyroid hormone harmonization. Ther Adv Endocrinol Metab 2019;10:2042018819897049. [PMID: 31903181 DOI: 10.1177/2042018819897049] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
93 Robier C, Kolbus N, Demel U. Anti-streptavidin antibodies as a cause of false-positive results of streptavidin-based autoantibody assays. Clinical Chemistry and Laboratory Medicine (CCLM) 2019;58:e5-e7. [DOI: 10.1515/cclm-2019-0500] [Reference Citation Analysis]
94 Mirjanic-Azaric B, Jerin A, Radic Z. Thyroid stimulating hormone values of clinical decisions of hypothyroidism measurement by three different automated immunoassays. Scand J Clin Lab Invest 2020;80:151-5. [PMID: 31841041 DOI: 10.1080/00365513.2019.1703215] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
95 Bowen R, Benavides R, Colón-franco JM, Katzman BM, Muthukumar A, Sadrzadeh H, Straseski J, Klause U, Tran N. Best practices in mitigating the risk of biotin interference with laboratory testing. Clinical Biochemistry 2019;74:1-11. [DOI: 10.1016/j.clinbiochem.2019.08.012] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]
96 Dieu X, Sueur G, Moal V, Boux de Casson F, Bouzamondo N, Bouhours N, Briet C, Illouz F, Reynier P, Coutant R, Rodien P, Mirebeau-prunier D. Apparent resistance to thyroid hormones: From biological interference to genetics. Annales d'Endocrinologie 2019;80:280-5. [DOI: 10.1016/j.ando.2019.06.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
97 Stieglitz HM, Korpi-Steiner N. Characterization of biotin interference in 21 Vitros 5600 immunoassays and risk mitigation for patient safety at a large academic medical center. Clin Biochem 2020;75:53-61. [PMID: 31677994 DOI: 10.1016/j.clinbiochem.2019.09.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
98 Razvi S, Bhana S, Mrabeti S. Challenges in Interpreting Thyroid Stimulating Hormone Results in the Diagnosis of Thyroid Dysfunction. J Thyroid Res 2019;2019:4106816. [PMID: 31662841 DOI: 10.1155/2019/4106816] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 5.3] [Reference Citation Analysis]
99 Thayakaran R, Adderley NJ, Sainsbury C, Torlinska B, Boelaert K, Šumilo D, Price M, Thomas GN, Toulis KA, Nirantharakumar K. Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study. BMJ 2019;366:l4892. [PMID: 31481394 DOI: 10.1136/bmj.l4892] [Cited by in Crossref: 41] [Cited by in F6Publishing: 49] [Article Influence: 10.3] [Reference Citation Analysis]
100 Favresse J, Lippi G, Roy PM, Chatelain B, Jacqmin H, Ten Cate H, Mullier F. D-dimer: Preanalytical, analytical, postanalytical variables, and clinical applications. Crit Rev Clin Lab Sci 2018;55:548-77. [PMID: 30694079 DOI: 10.1080/10408363.2018.1529734] [Cited by in Crossref: 64] [Cited by in F6Publishing: 54] [Article Influence: 16.0] [Reference Citation Analysis]
101 Haddad RA, Giacherio D, Barkan AL. Interpretation of common endocrine laboratory tests: technical pitfalls, their mechanisms and practical considerations. Clin Diabetes Endocrinol 2019;5:12. [PMID: 31367466 DOI: 10.1186/s40842-019-0086-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
102 Beck-Peccoz P, Giavoli C, Lania A. A 2019 update on TSH-secreting pituitary adenomas. J Endocrinol Invest 2019;42:1401-6. [PMID: 31175617 DOI: 10.1007/s40618-019-01066-x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 8.8] [Reference Citation Analysis]
103 Bayart J, Favresse J, Melnik E, Lardinois B, Fillée C, Maiter D, Gruson PD. Erroneous thyroid and steroid hormones profile due to anti-streptavidin antibodies. Clinical Chemistry and Laboratory Medicine (CCLM) 2019;57:e255-8. [DOI: 10.1515/cclm-2018-1355] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
104 Koch CA, Petersenn S. Neuroendocrine neoplasms – think about it and choose the most appropriate diagnostic and therapeutic steps. Rev Endocr Metab Disord 2018;19:107-9. [DOI: 10.1007/s11154-018-9472-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]